{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:19:15Z","timestamp":1760833155652,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bmcl.2021.128420","type":"journal-article","created":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T11:06:06Z","timestamp":1635591966000},"page":"128420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of novel aminosaccharide-based sulfonamide derivatives as potential carbonic anhydrase II inhibitors"],"prefix":"10.1016","volume":"53","author":[{"given":"Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-lian","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-yu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-bi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bmcl.2021.128420_b0005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2021.128420_b0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3109\/14756366.2014.910202","article-title":"An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria?","volume":"30","author":"Capasso","year":"2015","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2021.128420_b0015","doi-asserted-by":"crossref","unstructured":"S. Kumar, S. Rulhania, S. Jaswal, V. Monga, Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors, Eur J Med Chem. 209 (2021) 112923-112923.","DOI":"10.1016\/j.ejmech.2020.112923"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128420_b0020","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.bmc.2012.04.044","article-title":"Structure, function and applications of carbonic anhydrase isozymes","volume":"21","author":"Imtaiyaz Hassan","year":"2013","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2021.128420_b0025","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/17460441.2020.1743676","article-title":"Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery","volume":"15","author":"Supuran","year":"2020","journal-title":"Exp Opin Drug Discov"},{"key":"10.1016\/j.bmcl.2021.128420_b0030","doi-asserted-by":"crossref","unstructured":"Frost SC. Physiological functions of the alpha class of carbonic anhydrases. Carbonic anhydrase: mechanism, regulation, links to disease, and industrial applications, Springer, 2014 9-30.","DOI":"10.1007\/978-94-007-7359-2_2"},{"key":"10.1016\/j.bmcl.2021.128420_b0035","first-page":"539","article-title":"Visual prognosis in advanced glaucoma: a comparison of medical and surgical therapy for retention of vision in 101 eyes with advanced glaucoma","volume":"75","author":"Kolker","year":"1977","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"10.1016\/j.bmcl.2021.128420_b0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/14756366.2019.1705293","article-title":"Design, synthesis and biological evaluation of carbohydrate-based sulphonamide derivatives as topical antiglaucoma agents through selective inhibition of carbonic anhydrase II","volume":"35","author":"Hou","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2021.128420_b0045","doi-asserted-by":"crossref","unstructured":"Ghorai S, Pulya S, Ghosh K, Panda P, Ghosh B, Gayen S, Structure-activity relationship of human carbonic anhydrase-II inhibitors: Detailed insight for future development as anti-glaucoma agents, Bioorg Chem 95 (2020) 103557-103557.","DOI":"10.1016\/j.bioorg.2019.103557"},{"issue":"4","key":"10.1016\/j.bmcl.2021.128420_b0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.bmcl.2012.12.058","article-title":"A multivalent approach towards linked dual-pharmacology prostaglandin F receptor agonist\/carbonic anhydrase-II inhibitors for the treatment of glaucoma","volume":"23","author":"Long","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"23","key":"10.1016\/j.bmcl.2021.128420_b0055","doi-asserted-by":"crossref","first-page":"6565","DOI":"10.1016\/j.bmcl.2009.10.036","article-title":"Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma","volume":"19","author":"Steele","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"21","key":"10.1016\/j.bmcl.2021.128420_b0060","doi-asserted-by":"crossref","first-page":"115086","DOI":"10.1016\/j.bmc.2019.115086","article-title":"Highly hydrophilic 1,3-oxazol-5-yl benzenesulfonamide inhibitors of carbonic anhydrase II for reduction of glaucoma-related intraocular pressure","volume":"27","author":"Kalinin","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2021.128420_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2017.03.023","article-title":"Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site","volume":"132","author":"Hou","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128420_b0070","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/jm9900523","article-title":"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic\/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?","volume":"42","author":"Scozzafava","year":"1999","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128420_b0075","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/S0968-0896(99)00190-X","article-title":"Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic\/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?","volume":"7","author":"Borras","year":"1999","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2021.128420_b0080","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/jm061320h","article-title":"Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides","volume":"50","author":"Wilkinson","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128420_h0085","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.bmcl.2006.12.099","article-title":"Carbonic anhydrase inhibitors: binding of an antiglaucoma glycosyl-sulfanilamide derivative to human isoform II and its consequences for the drug design of enzyme inhibitors incorporating sugar moieties","volume":"17","author":"Di","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.128420_h0090","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1021\/jm701426t","article-title":"Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides","volume":"51","author":"Wilkinson","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128420_h0095","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/med.20141","article-title":"Therapeutic applications of glycosidic carbonic anhydrase inhibitors","volume":"29","author":"Winum","year":"2009","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmcl.2021.128420_h0100","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.bmc.2012.10.043","article-title":"Glycosidic carbonic anhydrase IX inhibitors: a sweet approach against cancer","volume":"21","author":"Winum","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2021.128420_b0090","doi-asserted-by":"crossref","first-page":"5096","DOI":"10.1016\/j.bmcl.2007.07.019","article-title":"Carbonic anhydrase inhibitors: Selective inhibition of the extracellular, tumor-associated isoforms IX and XII over isozymes I and II with glycosyl-thioureido-sulfonamides","volume":"17","author":"Smaine","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.128420_b0095","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1021\/jm200892s","article-title":"Targeting hypoxic tumor cell viability with carbohydrate-based carbonic anhydrase IX and XII inhibitors","volume":"54","author":"Morris","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128420_b0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/13543776.10.5.575","article-title":"Carbonic anhydrase inhibitors and their therapeutic potential","volume":"10","author":"Supuran","year":"2000","journal-title":"Exp Opin Therap Pat"},{"key":"10.1016\/j.bmcl.2021.128420_b0105","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejmech.2015.06.022","article-title":"Probing the \u2018bipolar\u2019 nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms","volume":"101","author":"Krasavin","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2021.128420_b0110","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/acschembio.7b00958","article-title":"Rational-differential design of highly specific glycomimetic ligands: targeting DC-SIGN and excluding Langerin recognition","volume":"13","author":"Porkolab","year":"2018","journal-title":"ACS Chem. Bio."},{"key":"10.1016\/j.bmcl.2021.128420_b0115","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.carres.2012.01.002","article-title":"Koenigs-Knorr reaction of fusel alcohols with methyl (1-bromo-2,3,4-tri-O-acetyl-a-D-glucopyranosid) urinate leading to the protected alkyl glucuronides-crystal structures and high resolution 1H and 13C NMR data","volume":"352","author":"M\u00f6nch","year":"2012","journal-title":"Carbohyd. Res."},{"key":"10.1016\/j.bmcl.2021.128420_b0120","doi-asserted-by":"crossref","unstructured":"S. Hao, X. Cheng, X. Wang, R. An, H. Xu, M. Guo, C. Li, Y. Wang, Z. Hou, C. Guo. Design, synthesis and biological evaluation of novel carbohydrate-based sulfonamide derivatives as antitumor agents, Bioorg Chem104 (2020) 104237-104237.","DOI":"10.1016\/j.bioorg.2020.104237"},{"key":"10.1016\/j.bmcl.2021.128420_b0125","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.bmcl.2014.04.053","article-title":"Design and synthesis of 3,4-dihydro-2H-benzo[h]chromene derivatives as potential NF-\u03baB inhibitors","volume":"24","author":"Choi","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2021.128420_b0130","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1002\/ejoc.201300523","article-title":"Synthesis of Phosphonoglycine Backbone Units for the Development of Phosphono Peptide Nucleic Acids","volume":"2013","author":"Bogdan","year":"2013","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.bmcl.2021.128420_b0135","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/acs.chemrestox.0c00319","article-title":"Diclofenac Sodium Triggers p53-Dependent Apoptosis in Human Corneal Epithelial Cells via ROS-Mediated Crosstalk","volume":"34","author":"Li","year":"2021","journal-title":"Chem Res Toxicol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21006478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X21006478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:42:33Z","timestamp":1760773353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X21006478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":30,"alternative-id":["S0960894X21006478"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128420","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel aminosaccharide-based sulfonamide derivatives as potential carbonic anhydrase II inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2021.128420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"128420"}}